What's breaking now, across thousands of outlets.
(RTTNews) - Belite Bio (BLTE) announced the submission of a New Drug Application to the Ministry of Health, Labour, and Welfare in Japan for tinlarebant in Stargardt disease type 1. Tinlarebant has been designated a SAKIGAKE pharmaceutical product for accelerated review and the N
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Yuancheng (Ryan) Lu is obsessed with aging. And with eyes. As he steps outside the Whitehead Institute in Cambridge, Massachusetts, his aviator glasses darken automatically in the sun.
Yuancheng (Ryan) Lu is obsessed with aging. And with eyes. As he steps outside the Whitehead Institute in Cambridge, Massachusetts, his aviator glasses darken automatically in the sun.
Learning how to improve child immunity naturally starts with supporting the habits that help the immune system work properly.
Researchers have found a potential way to attack prostate cancers that evade treatment by changing their cellular identity.
Researchers have found a potential way to attack prostate cancers that evade treatment by changing their cellular identity.
As South Africa rolls out the six-monthly HIV prevention injection, Lenacapavir, four people from high-risk groups explain why they chose the shot over daily pills and what their clinic experience was…
